Overview
Profile
Experience
Kim & Chang (2009-Present)
J.W. Suh & Partners (2003-2004)
Central international law firm (2002)
Y.S. Chang & Associates (1999-2000)
Representative ActivitiesView All
Publications/Activities
- "Unique Glycoform-Dependent Monoclonal Antibodies for Mouse Mucin 21," Int J Mol Sci, 23(12), 6718 (2022)
- "Mucin 21 in esophageal squamous epithelia and carcinomas: analysis with glycoform-specific monoclonal antibodies," Glycobiology, 22(9), 1218-1226 (2012)
- "Mucin 21/Epiglycanin Modulates Cell Adhesion," J Biol Chem, 285(28), 21233-21240 (2010)
Education
University of Pennsylvania School of Law (LL.M., 2017)
Korea National Open University (LL.B., 2015)
Graduate School of Pharmaceutical Sciences, University of Tokyo (Ph.D., 2009)
College of Pharmacy, Seoul National University (B.A., 1998)
Qualifications
Admitted to bar, Illinois, 2017
Admitted to patent bar, Korea, 2001
Registered Pharmacist of Korea, 1999
Languages
Korean, English and Japanese